Polymer/lipid hybrid NPs with targeting peptide CTCE and carrying p53 mRNAs (CTCE-p53 NPs) can actively target CXCR4 chemokine receptors that are expressed in hepatocellular carcinoma. The gene discussed is TP53; the disease is hepatocellular carcinoma.